Literature DB >> 32130898

Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid Production.

Valentin Sencio1, Adeline Barthelemy1, Luciana P Tavares2, Marina G Machado3, Daphnée Soulard1, Céline Cuinat4, Celso Martins Queiroz-Junior2, Marie-Louise Noordine4, Sophie Salomé-Desnoulez1, Lucie Deryuter1, Benoit Foligné5, Céline Wahl6, Benoit Frisch7, Angelica T Vieira2, Christophe Paget1, Graeme Milligan8, Trond Ulven9, Isabelle Wolowczuk1, Christelle Faveeuw1, Ronan Le Goffic10, Muriel Thomas4, Stéphanie Ferreira6, Mauro M Teixeira2, François Trottein11.   

Abstract

Secondary bacterial infections often complicate viral respiratory infections. We hypothesize that perturbation of the gut microbiota during influenza A virus (IAV) infection might favor respiratory bacterial superinfection. Sublethal infection with influenza transiently alters the composition and fermentative activity of the gut microbiota in mice. These changes are attributed in part to reduced food consumption. Fecal transfer experiments demonstrate that the IAV-conditioned microbiota compromises lung defenses against pneumococcal infection. In mechanistic terms, reduced production of the predominant short-chain fatty acid (SCFA) acetate affects the bactericidal activity of alveolar macrophages. Following treatment with acetate, mice colonized with the IAV-conditioned microbiota display reduced bacterial loads. In the context of influenza infection, acetate supplementation reduces, in a free fatty acid receptor 2 (FFAR2)-dependent manner, local and systemic bacterial loads. This translates into reduced lung pathology and improved survival rates of double-infected mice. Lastly, pharmacological activation of the SCFA receptor FFAR2 during influenza reduces bacterial superinfection.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acetate; bacterial superinfection; food restriction; free fatty acid receptor 2; gut microbiota; influenza A virus; macrophages; microbial dysbiosis; short-chain fatty acid

Mesh:

Substances:

Year:  2020        PMID: 32130898     DOI: 10.1016/j.celrep.2020.02.013

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  81 in total

Review 1.  The use of fecal microbiota transplant in sepsis.

Authors:  Robert Keskey; Jennifer T Cone; Jennifer R DeFazio; John C Alverdy
Journal:  Transl Res       Date:  2020-07-07       Impact factor: 7.012

2.  Supplementing the Diet with Sodium Propionate Suppresses the Severity of Viral Immuno-inflammatory Lesions.

Authors:  Deepak Sumbria; Engin Berber; Barry T Rouse
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

3.  Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection.

Authors:  David Groeger; Elisa Schiavi; Ray Grant; Magdalena Kurnik-Łucka; David Michalovich; Rick Williamson; Soren Beinke; Barry Kiely; Cezmi A Akdis; Edith M Hessel; Fergus Shanahan; Liam O' Mahony
Journal:  EBioMedicine       Date:  2020-09-11       Impact factor: 8.143

4.  Intestinal Microbiota in the SARS-CoV-2 Infection: What Is Known?

Authors:  Patrícia Brito Rodrigues; Arilson Bernardo Dos Santos Pereira Gomes; Lívia Moreira Genaro; Lívia Bitencourt Pascoal; Ana Paula Duarte de Souza; Raquel Franco Leal; Marco Aurélio Ramirez Vinolo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Influenza Virus Infection Impairs the Gut's Barrier Properties and Favors Secondary Enteric Bacterial Infection through Reduced Production of Short-Chain Fatty Acids.

Authors:  Valentin Sencio; Alexandre Gallerand; Marina Gomes Machado; Lucie Deruyter; Séverine Heumel; Daphnée Soulard; Johanna Barthelemy; Céline Cuinat; Angelica T Vieira; Adeline Barthelemy; Luciana P Tavares; Rodolphe Guinamard; Stoyan Ivanov; Corinne Grangette; Mauro M Teixeira; Benoit Foligné; Isabelle Wolowczuk; Ronan Le Goffic; Muriel Thomas; François Trottein
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

6.  Transkingdom Interactions Important for the Pathogenesis of Human Viruses.

Authors:  Andrew Nishimoto; Nicholas Wohlgemuth; Jason Rosch; Stacey Schultz-Cherry; Valerie Cortez; Hannah M Rowe
Journal:  J Infect Dis       Date:  2021-06-16       Impact factor: 5.226

7.  Gut Microbiota May Not Be Fully Restored in Recovered COVID-19 Patients After 3-Month Recovery.

Authors:  Yu Tian; Kai-Yi Sun; Tian-Qing Meng; Zhen Ye; Shi-Meng Guo; Zhi-Ming Li; Cheng-Liang Xiong; Ying Yin; Hong-Gang Li; Li-Quan Zhou
Journal:  Front Nutr       Date:  2021-05-13

8.  Gut microbiota involved in leptospiral infections.

Authors:  Xufeng Xie; Jiuxi Liu; Xi Chen; Shilei Zhang; Ruibo Tang; Xiaoyu Wu; Wenlong Zhang; Yongguo Cao
Journal:  ISME J       Date:  2021-09-29       Impact factor: 10.302

Review 9.  Is the oral microbiome a source to enhance mucosal immunity against infectious diseases?

Authors:  Camille Zenobia; Karla-Luise Herpoldt; Marcelo Freire
Journal:  NPJ Vaccines       Date:  2021-06-02       Impact factor: 7.344

Review 10.  Short-Chain Fatty Acids as a Potential Treatment for Infections: a Closer Look at the Lungs.

Authors:  Marina Gomes Machado; Valentin Sencio; François Trottein
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.